v3.26.1
Debt - Schedule of Debt (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Debt Instrument [Roll Forward]    
Payments for sale of future revenues $ 0 $ (2,872)
DRI Healthcare Acquisitions LP | License Agreement    
Debt Instrument [Roll Forward]    
Deferred royalty obligation related to the sale of future revenues, net as of December 31, 2025 58,605  
Payments for sale of future revenues (5,000)  
Non-cash interest expense associated with sale of future revenues 1,009  
Amortization of issuance costs 63  
Deferred royalty obligation related to the sale of future revenues, net as of March 31, 2026 $ 54,677